找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antisense Therapeutics; M. Ian Phillips Book 2005Latest edition Humana Press 2005 RNA.apoptosis.cancer.cancer therapy.cell.drug.drug deliv

[復(fù)制鏈接]
查看: 9883|回復(fù): 51
樓主
發(fā)表于 2025-3-21 19:05:47 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Antisense Therapeutics
影響因子2023M. Ian Phillips
視頻videohttp://file.papertrans.cn/159/158676/158676.mp4
發(fā)行地址Includes supplementary material:
學(xué)科分類Methods in Molecular Medicine
圖書封面Titlebook: Antisense Therapeutics;  M. Ian Phillips Book 2005Latest edition Humana Press 2005 RNA.apoptosis.cancer.cancer therapy.cell.drug.drug deliv
影響因子A timely primer on the new reality of antisense and RNA inhibition for treating a broad range of diseases. The authors show how antisense oligonucleotides are being designed and studied in relation to hypertension, various cancers, inflammatory bowel disease, brain disorders, the blood-brain barrier, and drug delivery.Highlights include RNA-based therapies for many diseases, up-to-date methods and applications, and insight into the enormous potential to provide a new generation of drugs.
Pindex Book 2005Latest edition
The information of publication is updating

書目名稱Antisense Therapeutics影響因子(影響力)




書目名稱Antisense Therapeutics影響因子(影響力)學(xué)科排名




書目名稱Antisense Therapeutics網(wǎng)絡(luò)公開度




書目名稱Antisense Therapeutics網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Antisense Therapeutics被引頻次




書目名稱Antisense Therapeutics被引頻次學(xué)科排名




書目名稱Antisense Therapeutics年度引用




書目名稱Antisense Therapeutics年度引用學(xué)科排名




書目名稱Antisense Therapeutics讀者反饋




書目名稱Antisense Therapeutics讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:19:14 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:19:31 | 只看該作者
地板
發(fā)表于 2025-3-22 06:12:47 | 只看該作者
Antisense Therapeutics for Hypertension of hypertension, the number of patients with controlled hypertension is about 27% in the United States. In all other countries studied, even those such as the United Kingdom and Canada, where cost is not a major factor, patient compliance is even worse. Part of the reason for this problem is that c
5#
發(fā)表于 2025-3-22 11:49:03 | 只看該作者
6#
發(fā)表于 2025-3-22 15:46:26 | 只看該作者
Clinical Studies of Antisense Oligonucleotides for Cancer Therapyhemotherapeutic drugs designed to perturb DNA synthesis or the mitotic event. The development of cytotoxic agents has resulted in improvements in the treatment of leukemia, lymphoma, testicular cancer, and many other solid tumor types (.). Hormone-based drugs have also been useful for breast and pro
7#
發(fā)表于 2025-3-22 18:40:52 | 只看該作者
Antisense Therapy in Clinical Oncologyan antisense oligonucleotide (AS-ODN) to the target mRNA makes the antisense strategy attractive for selectively modulating the expression of genes involved in the pathogenesis of malignant or nonmalignant diseases. One antisense drug has been approved for local therapy of cytomegalovirus (CMV) reti
8#
發(fā)表于 2025-3-22 23:45:30 | 只看該作者
Radionuclide-Peptide Nucleic Acid in Diagnosis and Treatment of Pancreatic Cancerreas (hereafter simply referred to as pancreatic cancer) occurs more frequently in African-Americans than in European-Americans. The disease progresses rapidly. Pancreatic cancer is usually refractory to treatment, with a median survival time of 12 mo. Overall, only 1% of patients live more than 5 y
9#
發(fā)表于 2025-3-23 02:17:08 | 只看該作者
10#
發(fā)表于 2025-3-23 06:32:46 | 只看該作者
Induction of Tumor Cell Apoptosis and Chemosensitization by Antisense Strategiese use of antisense oligodeoxynucleotides (AS-DONs) directed against gene products overexpressed in tumor cells in synergy with other anticancer agents. In contrast to the low basal levels of the mitogen-dependent cyclin D1 and of the DNA-damage-inducible p53 tumor suppressor protein, tumors with gre
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-25 18:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
中阳县| 乌鲁木齐县| 宜宾市| 北流市| 仙居县| 安达市| 绵阳市| 永寿县| 大悟县| 乌审旗| 灌云县| 青浦区| 林口县| 青冈县| 上杭县| 通化市| 长治县| 镇原县| 隆安县| 禹城市| 托克托县| 玛沁县| 小金县| 安吉县| 卓尼县| 龙口市| 日土县| 临江市| 黄浦区| 建湖县| 永修县| 海阳市| 平阳县| 高安市| 博罗县| 陆川县| 常德市| 连平县| 辽阳县| 阳泉市| 关岭|